Cas:15568-85-1 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione manufacturer & supplier

We serve Chemical Name:5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione CAS:15568-85-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione

Chemical Name:5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
CAS.NO:15568-85-1
Synonyms:1,3-Dioxane-4,6-dione, 5-(methoxymethylene)-2,2-dimethyl-;5-(methoxymethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione;5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
Molecular Formula:C8H10O5
Molecular Weight:186.162
HS Code:2934999090

Physical and Chemical Properties:
Melting point:132-134ºC
Boiling point:390.0±42.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.523
PSA:61.83000
Exact Mass:186.052826
LogP:-1.33

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,3-Dioxane-4,6-dione, 5-(methoxymethylene)-2,2-dimethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(methoxymethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione Use and application,1,3-Dioxane-4,6-dione, 5-(methoxymethylene)-2,2-dimethyl- technical grade,usp/ep/jp grade.


Related News: The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione vendor At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 5-(Methoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione factory ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak.